ISSN 1301 - 0883 / E-ISSN 1339 - 3886
 
 







 
 
Search





Investigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp., with E-test Combination Method [Eastern J Med]
Eastern J Med. 2019; 24(1): 96-101 | DOI: 10.5505/ejm.2019.66588  

Investigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp., with E-test Combination Method

Halim Kaysadu1, Yücel Duman2, Yusuf Yakupogulları2
1Medical Microbiology Department.of Bingol State Hospital, Bingol, Turkey.
2Medical Microbiology Department, Inonu University Medical Faculty, Malatya, Turkey

INTRODUCTION: The genus Brucella, which causes permanent infections in the reticuloendothelial system, is a significant cause of morbidity and mortality in humans. Clinically, a combination of two or three antibiotics is usually used for the treatment of brucellosis, but there is not enough information about the in vitro efficacy of these combinations.
METHODS: The in-vitro activity of the combination of doxycycline-rifampin, rifampin-cotrimoxazole, doxycycline-streptomycin, ciprofloxacin-cotrimoxazole and ciprofloxacin-streptomycin, which are most frequently used in clinical practice, was investigated by E-test combination method.
RESULTS: The results were evaluated using the Fractional Inhibitor Concentration Index and synergistic, additive and antagonist effects of these drugs were calculated. While the lowest MIK of the drug against to studied strains was detected as cotrimoxazole (as, 0.016 µg/ml), the highest MIK of the drug was detected as rifampin (as, 1.5 µg/ml). The combination of doxycycline-rifampin showed a synergistic activity to all tested strains (%100), and the combination of rifampin-cotrimoxazole exhibited antagonist activity to two strains (5%). The ratio of synergistic activities of ciprofloxacin-streptomycine and rifampin-cotrimoxazole combinations were found as 57.5% and 52.5%, orderly. The synergistic effect rates of combinations of doxycycline-streptomycin and ciprofloxacin-cotrimoxazole were 32.5% and 25%, respectively. The combination of rifampin with doxycycline showed a excellent synergistic effect against all strains.
DISCUSSION AND CONCLUSION: When clinical treatment is planned, testing the effectiveness of the antimicrobial combination will be beneficial in order for the treatment to be successful.In this context, we believe that in vitro detection of combination effects and single antibiotic susceptibility in the antimicrobial susceptibility tests against Brucella species would be beneficial.

Keywords: Brucella, Antibiotics, Synergism, Doxycycline, Rifampicin


Halim Kaysadu, Yücel Duman, Yusuf Yakupogulları. Investigation of Synergistic, Additive and Antagonist Effect of Antimicrobial Combinations Used for Brucella spp., with E-test Combination Method. Eastern J Med. 2019; 24(1): 96-101

Corresponding Author: Halim Kaysadu, Türkiye


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar




 
Copyright © 2019 Eastern Journal of Medicine. All Rights Reserved.
Home        |        Contact
LookUs & OnlineMakale